- Home
- Gastroenterology
- Long-Term Control of Advanced Endometrial Cancer with Lenvatinib and Pembrolizumab

6d3 min read
Medical Article
Introduction: Endometrial cancer (EC) is the sixth most common cancer among women worldwide and ranks as the fourth most common cancer in women in the UK, and sixth most common cause of death among women in the United States, with approximately 9,700 new cases diagnosed annually (1,2). Platinum-based chemotherapy, increasingly combined with immune

Long-Term Control of Advanced Endometrial Cancer with Lenvatinib and Pembrolizumab
517 Reached
Similar Content

Single-incision Laparoscopy for Gastrostomy
408 Reached2 Comments1 Likes

Intestinal Obstruction and Ileocolic Fistula due to Gossypiboma
863 Reached30 Comments15 Likes

Female with History of Amenorrhoea
3096 Reached10 Comments11 Likes

Role and Importance of DHA in Cognitive Development
524 Reached1 Likes

Woman with Complaint of Spontaneous Massive Rectal Prolapse
1866 Reached17 Comments9 Likes